Location History:
- Chicago, IL (US) (2011 - 2012)
- Douglas, MI (US) (2012 - 2023)
Company Filing History:
8 out of 2,119 
4 out of 2,489 
2 out of 170 
Years Active: 2011-2023
Title: The Innovative Contributions of Daniel Martin Watterson
Introduction
Daniel Martin Watterson is a notable inventor based in Douglas, MI (US). He has made significant contributions to the field of biotechnology, particularly in the development of MAP kinase modulators. With a total of 8 patents to his name, Watterson's work has the potential to impact the treatment of various neurodegenerative diseases.
Latest Patents
Watterson's latest patents focus on MAP kinase modulators and their uses. One of his inventions provides novel MAP kinase inhibitors and compositions comprising these inhibitors. In some embodiments, the MAP kinase inhibitors are identified as p38α MAP kinase inhibitors. The invention further outlines methods for treating diseases through the administration of these MAP kinase inhibitors or compositions that include them. Notably, the diseases targeted by these inventions include Alzheimer's Disease, ALS, Huntington's Disease, and Parkinson's Disease.
Career Highlights
Throughout his career, Watterson has worked with prestigious institutions such as Northwestern University and Columbia University. His research has contributed to advancements in understanding and treating complex diseases, showcasing his dedication to innovation in the medical field.
Collaborations
Watterson has collaborated with esteemed colleagues, including Linda J Van Eldik and Ottavio Arancio. These partnerships have further enriched his research and development efforts, leading to impactful inventions.
Conclusion
Daniel Martin Watterson's innovative work in the field of MAP kinase modulators highlights his commitment to advancing medical science. His contributions have the potential to significantly improve treatment options for various neurodegenerative diseases.